Tornier, which makes orthopedic implants for upper and lower extremity joints, raised $166 million by offering 8.75 million shares at $19, at the low end of the range of $19 to $21. Tornier plans to list on the NASDAQ under the symbol TRNX. BofA Merrill Lynch and J.P. Morgan acted as lead managers on the deal.
